concentration of sevoflurane associated to remifentanil required for insertion of the SupremeLaryngeal Mask versus Pro-Seal Laryngeal Mask

• Conditions: Patients requiring general anesthesia in whom the control of the airwayis usually done with a supraglottic device.; MedDRA version: 16.1Level: LLTClassification code 10018061Term: General anesthesiaSystem Organ Class: 100000004865; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]

• Registration Number: EUCTR2012-004163-50-ES
• Lead Sponsor: Fundación para la Investigación Biomédica del Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-02-25
• Last Update Posted: 16 November 2015

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

ASA I and II patients,
aged 18-75 years,
they are to be conducted outpatient surgery using laryngeal mask: minor procedures vascular surgery, abdominal, plastic, urological and minor orthopedic surgery
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 50
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

?background of of difficult airway
? difficult airway parameters, combining Mallamapati III or IV, thyromental distance <6 cm and decreased mouth opening < than 3 cm.
? Risk factors of aspiration of gastric contents: hiatal hernia symptoms frequent (daily or weekly)
? History of recent respiratory infection.
? Pregnancy and breastfeeding.
? Patient refusal to participate in the study.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified